Evidence map›Paper›PMID 30445491›Full record

ArticlePathogens and disease2018

Anti-Ace monoclonal antibody reduces Enterococcus faecalis aortic valve infection in a rat infective endocarditis model.

Kavindra V Singh, Kenneth L Pinkston, Peng Gao, Barrett R Harvey, Barbara E Murray

Open access · bronzeAbstract read
In one paragraph

Article in Pathogens and disease, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.3field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 11 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Antibiotics (Basel, Switzerland) · 2022
    Review
  5. Review
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Kavindra V SinghDivision of Infectious Diseases, Department of Internal Medicine, The University of Texas Health Science Center at Houston, 6431 Fannin St. Houston, TX 77030, USA.
Kenneth L PinkstonCenter for Molecular Imaging, Brown Foundation Institute of Molecular Medicine for the Prevention of Human Diseases, 1825 Pressler St, The University of Texas Health Science Center at Houston, Houston, TX 77030, USA.
Peng GaoCenter for Molecular Imaging, Brown Foundation Institute of Molecular Medicine for the Prevention of Human Diseases, 1825 Pressler St, The University of Texas Health Science Center at Houston, Houston, TX 77030, USA.
Barrett R HarveyCenter for Molecular Imaging, Brown Foundation Institute of Molecular Medicine for the Prevention of Human Diseases, 1825 Pressler St, The University of Texas Health Science Center at Houston, Houston, TX 77030, USA.
Barbara E MurrayDivision of Infectious Diseases, Department of Internal Medicine, The University of Texas Health Science Center at Houston, 6431 Fannin St. Houston, TX 77030, USA.
Brown Foundation · USThe University of Texas Health Science Center at Houston · US

Funding

Alternative Approaches for E. faecalis InfectionsR01AI047923 · NIAID · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI MURRAY, BARBARA E · 2010 to 2014
$3.1M
NIAID NIH HHS R01 AI047923
6 · The paper itself

Abstract

Ace (Adhesin to collagen from Enterococcus faecalis) is a cell-wall anchored protein that is expressed conditionally and is important for virulence in a rat infective endocarditis (IE) model. Previously, we showed that rats immunized with the collagen binding domain of Ace (domain A), or administered anti-Ace domain A polyclonal antibody, were less susceptible to E. faecalis endocarditis than sham-immunized controls. In this work, we demonstrated that a sub nanomolar monoclonal antibody (mAb), anti-Ace mAb70, significantly diminished E. faecalis binding to ECM collagen IV in in vitro adherence assays and that, in the endocarditis model, anti-Ace mAb70 pre-treatment significantly reduced E. faecalis infection of aortic valves. The effectiveness of anti-Ace mAb against IE in the rat model suggests it might serve as a beneficial agent for passive protection against E. faecalis infections.

Indexed as

AnimalsAntibodies, BacterialAntibodies, MonoclonalAortic ValveBacterial AdhesionBacterial ProteinsCarrier ProteinsDisease Models, AnimalEndocarditisEnterococcus faecalisGram-Positive Bacterial InfectionsImmunologic FactorsMaleRats, Sprague-DawleyTreatment OutcomeAce protein, EnterococcusAntibodies, BacterialAntibodies, MonoclonalBacterial ProteinsCarrier ProteinsImmunologic Factors

Identifiers

PMID30445491
PMCPMC6692841
OpenAlexW2900719996

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.